Published in Am J Cardiol on November 26, 2007
A reexamination of the PPAR-alpha activation mode of action as a basis for assessing human cancer risks of environmental contaminants. Environ Health Perspect (2009) 1.13
Platinum agent-induced hypersensitivity reactions: data mining of the public version of the FDA adverse event reporting system, AERS. Int J Med Sci (2011) 1.10
Myopathy with statin-fibrate combination therapy: clinical considerations. Nat Rev Endocrinol (2009) 0.88
New metabolites of fenofibrate in Sprague-Dawley rats by UPLC-ESI-QTOF-MS-based metabolomics coupled with LC-MS/MS. Xenobiotica (2009) 0.77
Pharmacological measures to increase HDL-C among high risk isolated low HDL cases: a randomized study amongst north Indians. Indian J Med Res (2013) 0.75
Hypertriglyceridaemia and risk of coronary artery disease. Nat Rev Cardiol (2017) 0.75
Statin-associated myopathy. JAMA (2003) 7.22
Effect of the magnitude of lipid lowering on risk of elevated liver enzymes, rhabdomyolysis, and cancer: insights from large randomized statin trials. J Am Coll Cardiol (2007) 4.93
Molecular and cellular basis of cardiovascular gender differences. Science (2005) 4.37
Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude. Am Heart J (2003) 3.73
Percutaneous coronary interventions for non-acute coronary artery disease: a quantitative 20-year synopsis and a network meta-analysis. Lancet (2009) 2.81
Statins, low-density lipoprotein cholesterol, and risk of cancer. J Am Coll Cardiol (2008) 2.77
Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta. Science (2002) 2.45
Association between statin-associated myopathy and skeletal muscle damage. CMAJ (2009) 2.41
Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure. Nat Med (2003) 2.33
Postmenopausal hormone therapy: an Endocrine Society scientific statement. J Clin Endocrinol Metab (2010) 2.27
The safety of rosuvastatin as used in common clinical practice: a postmarketing analysis. Circulation (2005) 2.19
Estrogen receptor inhibits mineralocorticoid receptor transcriptional regulatory function. Endocrinology (2014) 2.17
Effect of soy protein from differently processed products on cardiovascular disease risk factors and vascular endothelial function in hypercholesterolemic subjects. Am J Clin Nutr (2007) 2.15
Acquired long QT syndrome from stress cardiomyopathy is associated with ventricular arrhythmias and torsades de pointes. Heart Rhythm (2010) 2.15
Association between estrogen receptor alpha gene variation and cardiovascular disease. JAMA (2003) 2.10
HRT and the young at heart. N Engl J Med (2007) 2.07
Estrogen receptor-alpha mediates the protective effects of estrogen against vascular injury. Circ Res (2002) 2.05
Baseline and on-treatment high-density lipoprotein cholesterol and the risk of cancer in randomized controlled trials of lipid-altering therapy. J Am Coll Cardiol (2010) 1.95
Assessment of peripheral vascular endothelial function in the ambulatory setting. Vasc Med (2007) 1.88
Rapid estrogen receptor signaling is essential for the protective effects of estrogen against vascular injury. Circulation (2012) 1.78
Striatin assembles a membrane signaling complex necessary for rapid, nongenomic activation of endothelial NO synthase by estrogen receptor alpha. Proc Natl Acad Sci U S A (2004) 1.77
Variation in estrogen-related genes and cross-sectional and longitudinal blood pressure in the Framingham Heart Study. J Hypertens (2005) 1.77
17beta-estradiol reduces cardiomyocyte apoptosis in vivo and in vitro via activation of phospho-inositide-3 kinase/Akt signaling. Circ Res (2004) 1.74
Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society. Menopause (2008) 1.74
Clinical utility of endothelial function testing: ready for prime time? Circulation (2003) 1.62
Ventricular assist device therapy normalizes inducible nitric oxide synthase expression and reduces cardiomyocyte apoptosis in the failing human heart. J Am Coll Cardiol (2005) 1.61
Mechanically unloading the left ventricle before coronary reperfusion reduces left ventricular wall stress and myocardial infarct size. Circulation (2013) 1.58
Effects of statins on vascular structure and function: a systematic review. Am J Med (2004) 1.57
Statin use is associated with enhanced collateralization of severely diseased coronary arteries. Am Heart J (2003) 1.51
Statins and interstitial lung disease: a systematic review of the literature and of food and drug administration adverse event reports. Chest (2008) 1.51
High blood pressure arising from a defect in vascular function. Proc Natl Acad Sci U S A (2008) 1.50
High-density lipoproteins: a consensus statement from the National Lipid Association. J Clin Lipidol (2013) 1.50
Reduced diameter spheres increases the risk of chest blow-induced ventricular fibrillation (commotio cordis). Heart Rhythm (2011) 1.49
Renal actions of RGS2 control blood pressure. J Am Soc Nephrol (2010) 1.48
Estrogen receptors alpha and beta mediate distinct pathways of vascular gene expression, including genes involved in mitochondrial electron transport and generation of reactive oxygen species. Mol Endocrinol (2007) 1.47
Peripheral augmentation index and vascular inflammation in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant (2011) 1.47
Risk of adverse events with concomitant use of atorvastatin or simvastatin and glucose-lowering drugs (thiazolidinediones, metformin, sulfonylurea, insulin, and acarbose). Am J Cardiol (2002) 1.43
Comparison of the safety and efficacy of a combination tablet of niacin extended release and simvastatin vs simvastatin monotherapy in patients with increased non-HDL cholesterol (from the SEACOAST I study). Am J Cardiol (2008) 1.43
Comparison of the frequency of adverse events in patients treated with atorvastatin or simvastatin. Am J Cardiol (2003) 1.42
Relation of pulse pressure to blood pressure response to exercise in patients with hypertrophic cardiomyopathy. Am J Cardiol (2010) 1.41
Vascular endothelial dysfunction is associated with reversible myocardial perfusion defects in the absence of obstructive coronary artery disease. J Nucl Cardiol (2006) 1.41
Widowhood and severity of coronary artery disease: a multicenter study. Coron Artery Dis (2016) 1.39
Meta-analysis: statin therapy does not alter the association between low levels of high-density lipoprotein cholesterol and increased cardiovascular risk. Ann Intern Med (2010) 1.34
A novel mechanism for the beneficial vascular effects of high-density lipoprotein cholesterol: enhanced vasorelaxation and increased endothelial nitric oxide synthase expression. Am Heart J (2002) 1.33
Effects of statins on nonlipid serum markers associated with cardiovascular disease: a systematic review. Ann Intern Med (2003) 1.28
Estrogen attenuates left ventricular and cardiomyocyte hypertrophy by an estrogen receptor-dependent pathway that increases calcineurin degradation. Circ Res (2008) 1.26
Predictors of atrial fibrillation recurrence after radiofrequency catheter ablation: a systematic review. J Cardiovasc Electrophysiol (2010) 1.24
Systematic review: comparative effectiveness of radiofrequency catheter ablation for atrial fibrillation. Ann Intern Med (2009) 1.21
Estrogen-induced smooth muscle cell growth is regulated by tuberin and associated with altered activation of platelet-derived growth factor receptor-beta and ERK-1/2. J Biol Chem (2004) 1.19
Effects of extended-release niacin on lipoprotein particle size, distribution, and inflammatory markers in patients with coronary artery disease. Am J Cardiol (2006) 1.19
A call to action: women and peripheral artery disease: a scientific statement from the American Heart Association. Circulation (2012) 1.19
Estrogen receptor-alpha variants are associated with lipoprotein size distribution and particle levels in women: the Framingham Heart Study. Atherosclerosis (2005) 1.13
Hormone replacement therapy and the cardiovascular system lessons learned and unanswered questions. J Am Coll Cardiol (2006) 1.12
Prevalence and prognosis of chronic obstructive pulmonary disease among 8167 Middle Eastern patients with acute coronary syndrome. Clin Cardiol (2010) 1.12
Reduced endoglin activity limits cardiac fibrosis and improves survival in heart failure. Circulation (2012) 1.12
Utilization of emergency medical services by patients with acute coronary syndromes in the Arab Gulf States. J Emerg Med (2010) 1.10
Clinical characteristics, management, and outcomes of acute heart failure patients: observations from the Gulf acute heart failure registry (Gulf CARE). Eur J Heart Fail (2015) 1.10
The current state of niacin in cardiovascular disease prevention: a systematic review and meta-regression. J Am Coll Cardiol (2012) 1.08
Early repolarization associated with ventricular arrhythmias in patients with chronic coronary artery disease. Circ Arrhythm Electrophysiol (2010) 1.07
Large brachial artery diameter is associated with angiographic coronary artery disease in women. Am Heart J (2002) 1.06
17-beta-estradiol increases cardiac remodeling and mortality in mice with myocardial infarction. J Am Coll Cardiol (2003) 1.05
Association of prolonged QRS duration with ventricular tachyarrhythmias and sudden cardiac death in the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II). Heart Rhythm (2008) 1.05
Parasympathetic response in chick myocytes and mouse heart is controlled by SREBP. J Clin Invest (2008) 1.04
Gulf Survey of Atrial Fibrillation Events (Gulf SAFE): design and baseline characteristics of patients with atrial fibrillation in the Arab Middle East. Circ Cardiovasc Qual Outcomes (2011) 1.04
Risk of adverse events with fibrates. Am J Cardiol (2004) 1.03
Direct binding and regulation of RhoA protein by cyclic GMP-dependent protein kinase Iα. J Biol Chem (2012) 1.03
17 Beta-estradiol differentially affects left ventricular and cardiomyocyte hypertrophy following myocardial infarction and pressure overload. J Card Fail (2008) 1.02
Relation between high-density lipoprotein cholesterol and peripheral vasomotor function. Am J Cardiol (2003) 1.01
Association of estrogen receptor beta gene polymorphisms with left ventricular mass and wall thickness in women. Am J Hypertens (2005) 1.00
Rapid progress for non-nuclear estrogen receptor signaling. J Clin Invest (2010) 1.00
Comparison of characteristics, management practices, and outcomes of patients between the global registry and the gulf registry of acute coronary events. Am J Cardiol (2011) 1.00
Regulation of estrogen receptor alpha-mediated transcription by a direct interaction with protein phosphatase 2A. J Biol Chem (2002) 0.99
Protein phosphatase 2a (PP2A) binds within the oligomerization domain of striatin and regulates the phosphorylation and activation of the mammalian Ste20-Like kinase Mst3. BMC Biochem (2011) 0.99
Extended-release niacin reduces LDL particle number without changing total LDL cholesterol in patients with stable CAD. J Clin Lipidol (2008) 0.99
Protein kinase g iα inhibits pressure overload-induced cardiac remodeling and is required for the cardioprotective effect of sildenafil in vivo. J Am Heart Assoc (2012) 0.99
High-density lipoprotein increases the abundance of eNOS protein in human vascular endothelial cells by increasing its half-life. J Am Coll Cardiol (2003) 0.98
Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol. Am J Cardiol (2007) 0.98
Estrogen replacement and cardiomyocyte protection. Trends Cardiovasc Med (2006) 0.98
Augmentation index derived from peripheral arterial tonometry correlates with cardiovascular risk factors. Cardiol Res Pract (2011) 0.98
Is the WHI relevant to HRT started in the perimenopause? Endocrine (2004) 0.97
Gender disparities in the presentation, management and outcomes of acute coronary syndrome patients: data from the 2nd Gulf Registry of Acute Coronary Events (Gulf RACE-2). PLoS One (2013) 0.97
Pre-operative left atrial mechanical function predicts risk of atrial fibrillation following cardiac surgery. JACC Cardiovasc Imaging (2011) 0.96
Rapid estrogen receptor signaling mediates estrogen-induced inhibition of vascular smooth muscle cell proliferation. Arterioscler Thromb Vasc Biol (2013) 0.95
Estrogen receptor-mediated regulation of microRNA inhibits proliferation of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (2012) 0.94
Elevated augmentation index derived from peripheral arterial tonometry is associated with abnormal ventricular-vascular coupling. Clin Physiol Funct Imaging (2010) 0.94
MAP kinase mediates growth factor-induced nuclear translocation of estrogen receptor alpha. FEBS Lett (2002) 0.93
Role of SREBP-1 in the development of parasympathetic dysfunction in the hearts of type 1 diabetic Akita mice. Circ Res (2009) 0.93
Tendon rupture associated with simvastatin/ezetimibe therapy. Am J Cardiol (2007) 0.93
Missed opportunities in the management of ST-segment elevation myocardial infarction in the Arab Middle East: patient and physician impediments. Clin Cardiol (2010) 0.93
PDE5 inhibitor efficacy is estrogen dependent in female heart disease. J Clin Invest (2014) 0.92
Assessment of vascular endothelial function with peripheral arterial tonometry: information at your fingertips? Cardiol Rev (2009) 0.91
Short QT syndrome review. J Interv Card Electrophysiol (2008) 0.90
Age and clinical outcomes in patients presenting with acute coronary syndromes. J Cardiovasc Dis Res (2013) 0.90